WHO and ASCO Formed Global Cancer Care Partnership
The organizations partnered to expand oncology training and access to cancer research worldwide.
Updated on Oct. 14, 2026 in Cancer
Live Poll
Do you believe international medical partnerships effectively improve cancer care access in lower-income countries?
The World Health Organization and the American Society of Clinical Oncology have signed a formal collaboration agreement to improve international cancer care quality. The initiative aims to support 92% of families affected by cancer worldwide by strengthening research and professional capacity.
Why it matters
This partnership addresses significant disparities in oncology by prioritizing quality, accountability, and clinical trial access. By building a more capable global workforce, the collaboration seeks to improve patient survival rates in underserved regions.
The agreement is a strategic framework established to address the impact of cancer, which affects 92% of families globally. The impact of this collaboration on long-term survival metrics is currently unknown, as the initiative focuses on building foundational infrastructure and research access.
The players
World Health Organization
A specialized United Nations agency responsible for international public health, setting global standards and coordinating disease response.
American Society of Clinical Oncology
A professional medical organization that supports oncology practitioners, funds research, and promotes evidence-based cancer care standards.
The details
The collaboration leverages virtual and in-person training models to expand the oncology workforce, with curricula developed in consultation with member states. These training efforts are tailored to local contexts to ensure clinical competencies are relevant to individual countries. Additionally, the partnership focuses on strengthening systems that facilitate access to cancer clinical trials, aiming to standardize quality and accountability in care delivery.
Timeline
October 14, 2026: The formal collaboration agreement was signed.
2026: The WHO released its Global status report on cancer.
Health Landscape
This partnership follows the strategic priorities outlined in the 2026 WHO Global status report on cancer. It marks a significant effort to bridge the gap between global surveillance data and the practical reality of oncology service delivery in diverse health systems.
This global initiative aims to improve cancer care access and professional standards, which may eventually lead to higher quality care in your region. If you are navigating a cancer diagnosis, discussing trial opportunities and care standards with your oncology team remains a vital step.
The takeaway
The partnership between the WHO and ASCO highlights a global shift toward standardizing oncology education and improving research access. Patients and families affected by cancer should continue to inquire with their providers about the latest evidence-based treatment options and clinical trial availability.
Further reading
Explore the latest international updates on treatment and prevention strategies in our Cancer section.
Live Poll
Do you believe international medical partnerships effectively improve cancer care access in lower-income countries?
